Table 3.

Lipoprotein(a)-Associated ORs for Prevalence and Recurrence of Myocardial Infarction

Analysis	Myocardial Infarction	P Value	STEMI	P Value	Recurrent MI	P Value
Univariate
Lp(a) >230 nmol/L	1.91 (1.15-3.16)	0.012	2.22 (1.01-4.88)	0.047	13.74 (1.85-101.95)	0.010
Lp(a), per 100 nmol/L	1.19 (1.03-1.36)	0.017	1.14 (0.93-1.40)	0.207	1.48 (1.14-1.91)	0.003
Multivariable modela
Lp(a) >230 nmol/L	2.02 (1.20-3.39)	0.008	2.34 (1.05-5.21)	0.037	14.21 (1.91-105.81)	0.010
Lp(a), per 100 nmol/L	1.23 (1.06-1.43)	0.006	1.18 (0.95-1.46)	0.127	1.57 (1.18-2.07)	0.002
Multivariable modelb
Lp(a) >230 nmol/L	1.85 (1.03-3.33)	0.041	2.42 (1.02-5.72)	0.044	15.90 (2.07-122.37)	0.008
Lp(a), per 100 nmol/L	1.20 (1.01-1.42)	0.042	1.18 (0.93-1.49)	0.171	1.62 (1.19-2.20)	0.002

Values are OR (95% CI). Myocardial infarction and recurrent MI are defined according to the fourth universal definition of MI. STEMI prevalence was at the time of the first MI.

STEMI = ST-segment elevation myocardial infarction; other abbreviations as in Table 1.

^aAdjusted for age and sex.

^bAdjusted for age, sex, diabetes, hypertension, former smoking, total cholesterol (continuous), LDL-C (continuous), HDL-C (continuous), eGFR (continuous), and lipid-lowering therapy.